Share Price, page-11092

I’m going to sit on the sidelines with NEU for now, been a hell of a ride up from $1.70.

I feel the news flows now will be few and far between. Mostly dictated by Acadia quarterly updates and if there’s another revenue guidance downgrade, this will get hit pretty hard. But I’m hoping it doesn’t.

2591 will prove to be a blockbuster drug and I know I’m risking not holding when an acquisition offer comes, but I’m going to roll the dice.

Me selling has no reflection on not believing in NEU, moreso me having no faith in those who effectively price the share on the market.

Will definitely look to enter this again when the times right if I can (if the company still exists)